CITIZENS FOR ALTERNATIVES TO ANIMAL RESEARCH AND EXPERIMENTATION (CAARE)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2018–2021

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2021	—	5	1
2020	—	4	1
2019	—	4	1
2018	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BLUE MARBLE STRATEGY LLC	—	18

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	15
SENATE	15

Most frequently reported lobbying issues

Issue Code	Description	Reports
Animals	Animals	18
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1744117th Congress

Humane Research and Testing Act of 2021

2021 · fourth_quarter · Firm: BLUE MARBLE STRATEGY LLC

Cited source text and reported amounts

H.R.1744 - Humane Research and Testing Act, Humane Cosmetics Act, H.R.4101 - Humane and Existing Alternatives in Research and Testing Sciences Act

Client expense: — · Firm income: —

Matched citations: H.R.1744

H.R. 4101117th Congress

Humane and Existing Alternatives in Research and Testing Sciences Act of 2021

2021 · fourth_quarter · Firm: BLUE MARBLE STRATEGY LLC

Cited source text and reported amounts

H.R.1744 - Humane Research and Testing Act, Humane Cosmetics Act, H.R.4101 - Humane and Existing Alternatives in Research and Testing Sciences Act

Client expense: — · Firm income: —

Matched citations: H.R.4101

CITIZENS FOR ALTERNATIVES TO ANIMAL RESEARCH AND EXPERIMENTATION (CAARE) — Lobbying Disclosure | Poliscope